Your browser doesn't support javascript.
loading
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial.
Keil, Felix; Müller, Antonia M S; Berghold, Andrea; Riedl, Regina; Buxhofer-Ausch, Veronika; Schuster, Judith; Vorburger, Corinne; Böhm, Alexandra; Panny, Michael; Nösslinger, Thomas; Greil, Richard; Samaras, Panagiotis; Bencker, Celine; Rütti, Markus; Pabst, Thomas.
Afiliação
  • Keil F; 3rd Medical Department for Haematology and Oncology, Hanusch Hospital, Vienna, Austria.
  • Müller AMS; Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna, Vienna, Austria.
  • Berghold A; Department of Medical Oncology and Haematology, University Hospital Zurich, Zurich, Switzerland.
  • Riedl R; Institute for Medical Informatics, Statistics, and Documentation, Medical University Graz, Graz, Austria.
  • Buxhofer-Ausch V; Institute for Medical Informatics, Statistics, and Documentation, Medical University Graz, Graz, Austria.
  • Schuster J; Department of Internal Medicine I with Haematology, Stem Cell Transplantation, Haemostaseology and Medical Oncology, Ordensklinikum Linz Elisabethinen, Linz, Austria.
  • Vorburger C; Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
  • Böhm A; Austrian Group Medical Tumor Therapy (AGMT), Salzburg, Austria.
  • Panny M; Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland.
  • Nösslinger T; Haematological Health Care Centre of the ÖGK Mariahilf, Vienna, Austria.
  • Greil R; 3rd Medical Department for Haematology and Oncology, Hanusch Hospital, Vienna, Austria.
  • Samaras P; 3rd Medical Department for Haematology and Oncology, Hanusch Hospital, Vienna, Austria.
  • Bencker C; Austrian Group Medical Tumor Therapy (AGMT), Salzburg, Austria.
  • Rütti M; Cancer Cluster Salzburg (CCS), Salzburg, Austria.
  • Pabst T; III Medical Department with Haematology and Medical Oncology, Haemostaseology, Rheumatology and Infectious Diseases, Oncologic Centre, Paracelsus Medical University, Salzburg, Austria.
EClinicalMedicine ; 66: 102318, 2023 Dec.
Article em En | MEDLINE | ID: mdl-38024477
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: EClinicalMedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: EClinicalMedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria